Center of excellence for cell and gene therapy
Cell and gene therapies are poised to serve a global patient population. However, companies working in this space face challenges in terms of supply chain complexity. The close proximity of manufacturing to patients is key for the success of many cell and gene therapies.
As part of our global network of manufacturing sites, our two facilities in Geleen and Maastricht in the Netherlands help you overcome this challenge. The sites provide flexible capacity and serve customers who need a European manufacturing footprint.
Our Netherlands sites bring in significant expertise in cell and gene therapy manufacturing. As the CDMO that has supported a number of commercial autologous cell therapy products in Europe, we are committed to using our expertise to help you develop and commercialize your products quickly and efficiently, so that you can ultimately deliver therapy to patients in need of treatment.